Jong-Woo Paik, MD, PhD
- 2Articles
- 36.5KReads
- 2015–2020Active
- 26Collaborators
- 292Citations
About
Jong-Woo Paik, MD, PhD, has published research focusing on treatment-resistant depression and major depressive disorder. The work includes clinical trials assessing the long-term safety of esketamine nasal spray combined with oral antidepressants and comparing dose-initiation strategies of vilazodone following antidepressant switches. Publications appeared between 2015 and 2020 in Psychiatrist.com journals. Frequent collaborators include Ahmad Hatim Sulaiman, Allan H. Young, Ashwin A. Patkar, Cheng-Ta Li, and David Hough.
Publications
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder
August 6, 2015
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
